Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03253809 · ClinicalTrials.gov registry record · NA

Survey of QRS Frequency at Various Left Ventricular Pacing Sites for Cardiac Resynchronization

A NA study, sponsored by The Cleveland Clinic.

Terminated
Registry status
NA
Development phase
14
Enrollment target

NCT03253809 is a NA study that was terminated before completion, run by The Cleveland Clinic. The registered enrollment target is 14 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03253809, a NA study, was terminated before completion, sponsored by The Cleveland Clinic.

TERMINATED
Registry status
NA
Development phase
14 participants
Enrollment target

Study Summary

LV pacing at various sites with recording of ECG and subsequent signal analysis at different sites.

Interventions

  • DEVICE Biotronik Vision Guidewire

Trial Details

FieldValue
Enrollment Target 14 participants
Start Date 2017-07-12
Est. Completion 2021-11-02
Phase NA

Sponsor

The Cleveland Clinic

688 total trials

What the Registry Record Tells You About NCT03253809

The ClinicalTrials.gov registry entry for NCT03253809 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 14 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is The Cleveland Clinic, which has 688 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which Biotronik Vision Guidewire is the first listed.

NCT03253809 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT03253809 about?

NCT03253809 is a clinical study titled "Survey of QRS Frequency at Various Left Ventricular Pacing Sites for Cardiac Resynchronization". LV pacing at various sites with recording of ECG and subsequent signal analysis at different sites.

What is the current status of trial NCT03253809?

This trial is currently terminated. It is a NA study. The enrollment target is 14 participants. The study started on 2017-07-12. Estimated completion is 2021-11-02.

What interventions are being tested in trial NCT03253809?

The interventions under investigation include: Biotronik Vision Guidewire (DEVICE).

Who is sponsoring clinical trial NCT03253809?

This trial is sponsored by The Cleveland Clinic, which has 688 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.